Merck's BACE inhibitor fails P3 for AD









The stock price bounced, but still this is bad news for the BACE inhibitor Amgen is codeveloping with Novartis


DON'T YOU KNOW THE AMGEN-NOVARTIS DRUG WILL WORK BECAUSE AMGEN HAS THE MAGIC TOUCH!!!

AMGEN WILL MAKE BACE WORK AND CTEP AS WELL. AMGEN IS THE GOLDEN CHILD! THE MCKINSEY AND BCG CONSULTANTS AMGEN HIRES WILL FIX IT!
 




Is it true that Amgen gave up the European marketing rights on it's migraine drug to partner with Novartis on the Novartis BACE inhibitor? Looks like another bad Amgen BD deal.